Crossmark

Utility of blood as the clinical specimen for the diagnosis of ocular toxoplasmosis using uracil DNA glycosylase-supplemented loop-mediated isothermal amplification and real-time polymerase chain reaction assays based on REP-529 sequence and B1 gene

Crossref DOI link: https://doi.org/10.1186/s12879-022-07073-3

Published Online: 2022-01-25

Published Print: 2022-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Rahimi Esboei, Bahman

Fallahi, Shirzad

Zarei, Mohammad

Kazemi, Bahram

Mohebali, Mehdi

Shojaee, Saeedeh

Mousavi, Parisa

Teimouri, Aref

Mahmoudzadeh, Raziyeh

Salabati, Mirataollah

Keshavarz Valian, Hossein
License Information

Text and Data Mining valid from 2022-01-25

Version of Record valid from 2022-01-25
More Information

Article History

Received: 15 September 2021

Accepted: 18 January 2022

First Online: 25 January 2022

Declarations

:

: This study was carried out based on the ethical standards by institutional and/or national research committees and Helsinki Declaration, 1964. All experimental protocols were approved by the Ethical Committee of Tehran University of Medical Sciences, Tehran, Iran (Ethical no. 29998). Furthermore, informed consents were collected from all the participants before starting the study. Parental consent was obtained from the parent or guardian for participants less than 18 years old included in this study.

: Not applicable.

: The authors declare that we do not have any competing interests.

Document is current

Any future updates will be listed below